Can Noncommunicable Diseases Be Prevented? Lessons from Studies of Populations and Individuals

被引:161
作者
Ezzati, Majid [1 ]
Riboli, Elio
机构
[1] Univ London Imperial Coll Sci Technol & Med, MRC HPA Ctr Environm & Hlth, Sch Publ Hlth, London W2 1PG, England
基金
英国医学研究理事会;
关键词
CORONARY-HEART-DISEASE; SERUM-CHOLESTEROL CONCENTRATION; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; LUNG-CANCER; GLOBAL EPIDEMIOLOGY; ALCOHOL-CONSUMPTION; PHYSICAL-ACTIVITY; CERVICAL-CANCER; STOMACH-CANCER;
D O I
10.1126/science.1227001
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Noncommunicable diseases (NCDs)-mainly cancers, cardiovascular diseases, diabetes, and chronic respiratory diseases-are responsible for about two-thirds of deaths worldwide, mostly in low- and middle-income countries. There is an urgent need for policies and strategies that prevent NCDs by reducing their major risk factors. Effective approaches for large-scale NCD prevention include comprehensive tobacco and alcohol control through taxes and regulation of sales and advertising; reducing dietary salt, unhealthy fats, and sugars through regulation and well-designed public education; increasing the consumption of fresh fruits and vegetables, healthy fats, and whole grains by lowering prices and improving availability; and implementing a universal, effective, and equitable primary-care system that reduces NCD risk factors, including cardiometabolic risk factors and infections that are precursors to NCDs, through clinical interventions.
引用
收藏
页码:1482 / 1487
页数:6
相关论文
共 94 条
  • [1] Adler L., 1912, PRIMARY MALIGNANT GR
  • [2] Allamani A., 2007, CONTEMP DRUG PROBL, V34, P187, DOI DOI 10.1177/009145090703400203
  • [3] Cholesterol Control Beyond the Clinic: New York City's Trans Fat Restriction
    Angell, Sonia Y.
    Silver, Lynn Dee
    Goldstein, Gail P.
    Johnson, Christine M.
    Deitcher, Deborah R.
    Frieden, Thomas R.
    Bassett, Mary T.
    [J]. ANNALS OF INTERNAL MEDICINE, 2009, 151 (02) : 129 - W33
  • [4] [Anonymous], 2010, REV BRAS PSIQUIATR
  • [5] [Anonymous], 2003, MMWR, V52, P868
  • [6] [Anonymous], 2007, CONTEMP DRUG PROBL, DOI DOI 10.1177/009145090703400213
  • [7] Chronic diseases 3 - Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use
    Asaria, Perviz
    Chisholm, Dan
    Mathers, Colin
    Ezzati, Majid
    Beaglehole, Robert
    [J]. LANCET, 2007, 370 (9604) : 2044 - 2053
  • [8] Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
    Baigent, C.
    Blackwell, L.
    Emberson, J.
    Holland, L. E.
    Reith, C.
    Bhala, N.
    Peto, R.
    Barnes, E. H.
    Keech, A.
    Simes, J.
    Collins, R.
    [J]. LANCET, 2010, 376 (9753) : 1670 - 1681
  • [9] BAILIS R, 2005, LOGIC CIRCUITS CARBO, V308, P98, DOI DOI 10.1126/SCIENCE.1106881
  • [10] BEAGLEHOLE R, 2008, J GERONTOL B-PSYCHOL, V372, P940